Symbols / MRNA $49.20 -1.66% Moderna, Inc.
MRNA Chart
About
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 19.51B |
| Enterprise Value | 14.94B | Income | -2.82B | Sales | 1.94B |
| Book/sh | 21.95 | Cash/sh | 14.68 | Dividend Yield | — |
| Payout | 0.00% | Employees | 4700 | IPO | — |
| P/E | — | Forward P/E | -10.59 | PEG | — |
| P/S | 10.04 | P/B | 2.24 | P/C | — |
| EV/EBITDA | -5.22 | EV/Sales | 7.68 | Quick Ratio | 3.06 |
| Current Ratio | 3.29 | Debt/Eq | 15.09 | LT Debt/Eq | — |
| EPS (ttm) | -7.26 | EPS next Y | -4.65 | EPS Growth | — |
| Revenue Growth | -29.80% | Earnings | 2026-04-30 | ROA | -14.51% |
| ROE | -28.87% | ROIC | — | Gross Margin | -105.76% |
| Oper. Margin | -126.40% | Profit Margin | -145.16% | Shs Outstand | 396.59M |
| Shs Float | 368.43M | Short Float | 20.42% | Short Ratio | 6.35 |
| Short Interest | — | 52W High | 59.55 | 52W Low | 22.28 |
| Beta | 1.34 | Avg Volume | 10.89M | Volume | 4.63M |
| Target Price | $44.90 | Recom | Hold | Prev Close | $50.03 |
| Price | $49.20 | Change | -1.66% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-02 | main | Barclays | Equal-Weight → Equal-Weight | $48 |
| 2026-02-23 | main | Piper Sandler | Overweight → Overweight | $69 |
| 2026-02-17 | main | Goldman Sachs | Neutral → Neutral | $41 |
| 2026-02-17 | main | RBC Capital | Sector Perform → Sector Perform | $30 |
| 2026-02-17 | main | Evercore ISI Group | In-Line → In-Line | $35 |
| 2025-12-12 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $28 |
| 2025-12-12 | init | Jefferies | — → Hold | $30 |
| 2025-11-21 | reit | Piper Sandler | Overweight → Overweight | $63 |
| 2025-11-21 | main | RBC Capital | Sector Perform → Sector Perform | $25 |
| 2025-11-21 | main | Leerink Partners | Underperform → Underperform | $18 |
| 2025-11-10 | main | B of A Securities | Underperform → Underperform | $21 |
| 2025-11-07 | main | Barclays | Equal-Weight → Equal-Weight | $25 |
| 2025-10-23 | main | UBS | Buy → Buy | $40 |
| 2025-10-23 | main | JP Morgan | Underweight → Underweight | $25 |
| 2025-10-23 | main | Citigroup | Neutral → Neutral | $28 |
| 2025-10-20 | reit | Needham | Hold → Hold | — |
| 2025-10-10 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $32 |
| 2025-08-22 | main | Leerink Partners | Underperform → Underperform | $15 |
| 2025-08-04 | main | Barclays | Equal-Weight → Equal-Weight | $31 |
| 2025-07-22 | main | B of A Securities | Underperform → Underperform | $25 |
- Moderna, Inc. (MRNA) stock price, news, quote and history - Yahoo Finance UK Sun, 05 Apr 2026 00
- Moderna: Speculative Buy For Aggressive Investors Betting On mRNA's Future (NASDAQ:MRNA) - Seeking Alpha Mon, 06 Apr 2026 07
- Moderna (MRNA) stock dips while market gains: Key facts - MSN hu, 02 Apr 2026 23
- Moderna, Inc. (NASDAQ:MRNA) Given Consensus Recommendation of "Reduce" by Brokerages - MarketBeat hu, 02 Apr 2026 06
- 3 Healthcare Stocks We’re Skeptical Of - StockStory hu, 12 Mar 2026 07
- Jim Cramer Discusses the Moderna Rally and the Impact of FDA Leadership Changes - insidermonkey.com Mon, 06 Apr 2026 03
- Barclays Analyst Raises Price Target for Moderna (MRNA) to $48.0 - GuruFocus hu, 02 Apr 2026 14
- MRNA Stock Gains After CHMP Endorses COVID-19-Influenza Combo Shot - zacks.com Mon, 02 Mar 2026 08
- Healthcare among laggards in Q1; MRNA and DVA lead gainers while HUM drags - Seeking Alpha Wed, 01 Apr 2026 16
- Moderna (NASDAQ:MRNA) Price Target Raised to $48.00 at Barclays - MarketBeat hu, 02 Apr 2026 13
- Is Moderna (MRNA) Pricing Make Sense After A 96% One Year Share Price Jump - finance.yahoo.com Sat, 04 Apr 2026 08
- Militia Capital Partners LP Sells 49,000 Shares of Moderna, Inc. $MRNA - MarketBeat ue, 17 Mar 2026 07
- Moderna, Inc. (MRNA) Stock Forecasts - finance.yahoo.com ue, 31 Mar 2026 02
- Why Moderna (MRNA) Stock Is Trading Up Today - finance.yahoo.com Wed, 04 Mar 2026 08
- Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest - finance.yahoo.com Fri, 20 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
1,922.00
-39.92%
|
3,199.00
-52.64%
|
6,754.00
-64.22%
|
18,875.00
|
| Operating Revenue |
|
3,304.00
-26.85%
|
4,517.00
-44.93%
|
8,203.00
-55.50%
|
18,435.00
|
| Cost Of Revenue |
|
868.00
-40.71%
|
1,464.00
-68.80%
|
4,693.00
-13.35%
|
5,416.00
|
| Reconciled Cost Of Revenue |
|
868.00
-40.71%
|
1,464.00
-68.80%
|
4,693.00
-13.35%
|
5,416.00
|
| Gross Profit |
|
1,054.00
-39.25%
|
1,735.00
-15.82%
|
2,061.00
-84.69%
|
13,459.00
|
| Operating Expense |
|
4,128.00
-27.32%
|
5,680.00
-9.84%
|
6,300.00
+55.98%
|
4,039.00
|
| Research And Development |
|
3,132.00
-31.06%
|
4,543.00
-6.23%
|
4,845.00
+47.04%
|
3,295.00
|
| Selling General And Administration |
|
1,018.00
-13.29%
|
1,174.00
-24.21%
|
1,549.00
+36.84%
|
1,132.00
|
| Other Operating Expenses |
|
-22.00
+40.54%
|
-37.00
+60.64%
|
-94.00
+75.77%
|
-388.00
|
| Total Expenses |
|
4,996.00
-30.07%
|
7,144.00
-35.01%
|
10,993.00
+16.27%
|
9,455.00
|
| Operating Income |
|
-3,074.00
+22.08%
|
-3,945.00
+6.94%
|
-4,239.00
-145.00%
|
9,420.00
|
| Total Operating Income As Reported |
|
-3,074.00
+22.08%
|
-3,945.00
+6.94%
|
-4,239.00
-145.00%
|
9,420.00
|
| EBITDA |
|
-2,543.00
+25.07%
|
-3,394.00
+6.19%
|
-3,618.00
-137.04%
|
9,768.00
|
| Normalized EBITDA |
|
-2,538.00
+23.97%
|
-3,338.00
+7.74%
|
-3,618.00
-137.04%
|
9,768.00
|
| Reconciled Depreciation |
|
215.00
+13.76%
|
189.00
-69.57%
|
621.00
+78.45%
|
348.00
|
| EBIT |
|
-2,758.00
+23.03%
|
-3,583.00
+15.48%
|
-4,239.00
-145.00%
|
9,420.00
|
| Total Unusual Items |
|
-5.00
+91.07%
|
-56.00
+22.22%
|
-72.00
-260.00%
|
-20.00
|
| Total Unusual Items Excluding Goodwill |
|
-5.00
+91.07%
|
-56.00
+22.22%
|
-72.00
-260.00%
|
-20.00
|
| Net Income |
|
-2,822.00
+20.75%
|
-3,561.00
+24.46%
|
-4,714.00
-156.37%
|
8,362.00
|
| Pretax Income |
|
-2,768.00
+23.26%
|
-3,607.00
+8.50%
|
-3,942.00
-141.17%
|
9,575.00
|
| Net Non Operating Interest Income Expense |
|
304.00
-24.19%
|
401.00
-4.75%
|
421.00
+110.50%
|
200.00
|
| Interest Expense Non Operating |
|
10.00
-58.33%
|
24.00
-36.84%
|
38.00
+31.03%
|
29.00
|
| Net Interest Income |
|
304.00
-24.19%
|
401.00
-4.75%
|
421.00
+110.50%
|
200.00
|
| Interest Expense |
|
10.00
-58.33%
|
24.00
-36.84%
|
38.00
+31.03%
|
29.00
|
| Interest Income Non Operating |
|
314.00
-26.12%
|
425.00
+0.95%
|
421.00
+110.50%
|
200.00
|
| Interest Income |
|
314.00
-26.12%
|
425.00
+0.95%
|
421.00
+110.50%
|
200.00
|
| Other Income Expense |
|
2.00
+103.17%
|
-63.00
+49.19%
|
-124.00
-175.56%
|
-45.00
|
| Other Non Operating Income Expenses |
|
7.00
+200.00%
|
-7.00
+94.35%
|
-124.00
-175.56%
|
-45.00
|
| Gain On Sale Of Security |
|
-5.00
+91.07%
|
-56.00
+22.22%
|
-72.00
-260.00%
|
-20.00
|
| Tax Provision |
|
54.00
+217.39%
|
-46.00
-105.96%
|
772.00
-36.36%
|
1,213.00
|
| Tax Rate For Calcs |
|
0.00
+1546.67%
|
0.00
-93.93%
|
0.00
+65.35%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-1.05
-47.02%
|
-0.71
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-2,822.00
+20.75%
|
-3,561.00
+24.46%
|
-4,714.00
-156.37%
|
8,362.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
-2,822.00
+20.75%
|
-3,561.00
+24.46%
|
-4,714.00
-156.37%
|
8,362.00
|
| Net Income From Continuing And Discontinued Operation |
|
-2,822.00
+20.75%
|
-3,561.00
+24.46%
|
-4,714.00
-156.37%
|
8,362.00
|
| Net Income Continuous Operations |
|
-2,822.00
+20.75%
|
-3,561.00
+24.46%
|
-4,714.00
-156.37%
|
8,362.00
|
| Normalized Income |
|
-2,818.05
+19.62%
|
-3,505.71
+25.63%
|
-4,714.00
-156.37%
|
8,362.00
|
| Net Income Common Stockholders |
|
-2,822.00
+20.75%
|
-3,561.00
+24.46%
|
-4,714.00
-156.37%
|
8,362.00
|
| Diluted EPS |
|
—
|
-9.28
+24.74%
|
-12.33
-161.28%
|
20.12
|
| Basic EPS |
|
—
|
-9.28
+24.74%
|
-12.33
-158.00%
|
21.26
|
| Basic Average Shares |
|
—
|
384.00
+0.52%
|
382.00
-3.05%
|
394.00
|
| Diluted Average Shares |
|
—
|
384.00
+0.52%
|
382.00
-8.17%
|
416.00
|
| Diluted NI Availto Com Stockholders |
|
-2,822.00
+20.75%
|
-3,561.00
+24.46%
|
-4,714.00
-156.37%
|
8,362.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
12,338.00
-12.76%
|
14,142.00
-23.25%
|
18,426.00
-28.74%
|
25,858.00
|
| Current Assets |
|
6,544.00
-19.20%
|
8,099.00
-21.56%
|
10,325.00
-23.13%
|
13,431.00
|
| Cash Cash Equivalents And Short Term Investments |
|
5,799.00
-17.45%
|
7,025.00
-18.35%
|
8,604.00
-13.11%
|
9,902.00
|
| Cash And Cash Equivalents |
|
2,595.00
+34.67%
|
1,927.00
-33.71%
|
2,907.00
-9.30%
|
3,205.00
|
| Other Short Term Investments |
|
3,204.00
-37.15%
|
5,098.00
-10.51%
|
5,697.00
-14.93%
|
6,697.00
|
| Receivables |
|
284.00
-52.03%
|
592.00
-45.24%
|
1,081.00
-35.85%
|
1,685.00
|
| Accounts Receivable |
|
184.00
-48.60%
|
358.00
-59.87%
|
892.00
-35.60%
|
1,385.00
|
| Gross Accounts Receivable |
|
368.00
-47.28%
|
698.00
-55.93%
|
1,584.00
+14.37%
|
1,385.00
|
| Allowance For Doubtful Accounts Receivable |
|
-184.00
+45.88%
|
-340.00
+50.87%
|
-692.00
|
0.00
|
| Other Receivables |
|
13.00
-77.59%
|
58.00
-4.92%
|
61.00
+15.09%
|
53.00
|
| Taxes Receivable |
|
45.00
-61.54%
|
117.00
+69.57%
|
69.00
-54.00%
|
150.00
|
| Accrued Interest Receivable |
|
42.00
-28.81%
|
59.00
+0.00%
|
59.00
-3.28%
|
61.00
|
| Inventory |
|
153.00
+30.77%
|
117.00
-42.08%
|
202.00
-78.71%
|
949.00
|
| Raw Materials |
|
91.00
+44.44%
|
63.00
-61.35%
|
163.00
-71.65%
|
575.00
|
| Work In Process |
|
29.00
+11.54%
|
26.00
+73.33%
|
15.00
-92.68%
|
205.00
|
| Finished Goods |
|
33.00
+17.86%
|
28.00
+16.67%
|
24.00
-85.80%
|
169.00
|
| Prepaid Assets |
|
263.00
-14.33%
|
307.00
-12.29%
|
350.00
-58.87%
|
851.00
|
| Hedging Assets Current |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
45.00
-22.41%
|
58.00
-34.09%
|
88.00
+100.00%
|
44.00
|
| Total Non Current Assets |
|
5,794.00
-4.12%
|
6,043.00
-25.40%
|
8,101.00
-34.81%
|
12,427.00
|
| Net PPE |
|
2,853.00
-3.45%
|
2,955.00
+11.17%
|
2,658.00
+24.26%
|
2,139.00
|
| Gross PPE |
|
3,590.00
+3.10%
|
3,482.00
+12.65%
|
3,091.00
+10.51%
|
2,797.00
|
| Accumulated Depreciation |
|
-737.00
-39.85%
|
-527.00
-21.71%
|
-433.00
+34.19%
|
-658.00
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
78.00
+32.20%
|
59.00
+168.18%
|
22.00
+100.00%
|
11.00
|
| Buildings And Improvements |
|
1,183.00
+59.22%
|
743.00
|
0.00
|
—
|
| Machinery Furniture Equipment |
|
235.00
+29.83%
|
181.00
+81.00%
|
100.00
+69.49%
|
59.00
|
| Construction In Progress |
|
298.00
-71.81%
|
1,057.00
+22.91%
|
860.00
+206.05%
|
281.00
|
| Other Properties |
|
1,393.00
+12.79%
|
1,235.00
-22.18%
|
1,587.00
-20.09%
|
1,986.00
|
| Leases |
|
403.00
+94.69%
|
207.00
-60.34%
|
522.00
+13.48%
|
460.00
|
| Goodwill And Other Intangible Assets |
|
97.00
+5.43%
|
92.00
-4.17%
|
96.00
|
0.00
|
| Goodwill |
|
52.00
+0.00%
|
52.00
+0.00%
|
52.00
|
0.00
|
| Other Intangible Assets |
|
45.00
+12.50%
|
40.00
-9.09%
|
44.00
|
—
|
| Investments And Advances |
|
2,342.00
-6.62%
|
2,508.00
-47.12%
|
4,743.00
-43.27%
|
8,360.00
|
| Long Term Equity Investment |
|
6.00
-57.14%
|
14.00
-78.79%
|
66.00
+57.14%
|
42.00
|
| Non Current Accounts Receivable |
|
161.00
+65.98%
|
97.00
|
—
|
—
|
| Non Current Deferred Assets |
|
81.00
+0.00%
|
81.00
+0.00%
|
81.00
-91.75%
|
982.00
|
| Non Current Deferred Taxes Assets |
|
81.00
+0.00%
|
81.00
+0.00%
|
81.00
-91.75%
|
982.00
|
| Non Current Prepaid Assets |
|
100.00
-28.06%
|
139.00
-59.36%
|
342.00
|
0.00
|
| Other Non Current Assets |
|
160.00
-6.43%
|
171.00
-5.52%
|
181.00
-80.87%
|
946.00
|
| Total Liabilities Net Minority Interest |
|
3,688.00
+13.79%
|
3,241.00
-29.11%
|
4,572.00
-32.12%
|
6,735.00
|
| Current Liabilities |
|
1,987.00
-9.93%
|
2,206.00
-26.83%
|
3,015.00
-38.76%
|
4,923.00
|
| Payables And Accrued Expenses |
|
774.00
-32.70%
|
1,150.00
-27.22%
|
1,580.00
-35.40%
|
2,446.00
|
| Payables |
|
317.00
-21.73%
|
405.00
-30.53%
|
583.00
+8.97%
|
535.00
|
| Accounts Payable |
|
317.00
-21.73%
|
405.00
-22.12%
|
520.00
+6.78%
|
487.00
|
| Current Accrued Expenses |
|
457.00
-38.66%
|
745.00
-25.28%
|
997.00
-47.83%
|
1,911.00
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
420.00
+34.62%
|
312.00
+27.35%
|
245.00
+28.95%
|
190.00
|
| Total Tax Payable |
|
—
|
3.00
-95.24%
|
63.00
+31.25%
|
48.00
|
| Income Tax Payable |
|
—
|
3.00
-95.24%
|
63.00
+31.25%
|
48.00
|
| Current Debt And Capital Lease Obligation |
|
42.00
+13.51%
|
37.00
+48.00%
|
25.00
-87.24%
|
196.00
|
| Current Capital Lease Obligation |
|
42.00
+13.51%
|
37.00
+48.00%
|
25.00
-87.24%
|
196.00
|
| Current Deferred Liabilities |
|
99.00
-35.29%
|
153.00
-73.06%
|
568.00
-72.13%
|
2,038.00
|
| Current Deferred Revenue |
|
99.00
-35.29%
|
153.00
-73.06%
|
568.00
-72.13%
|
2,038.00
|
| Other Current Liabilities |
|
143.00
-22.28%
|
184.00
+348.78%
|
41.00
-22.64%
|
53.00
|
| Total Non Current Liabilities Net Minority Interest |
|
1,701.00
+64.35%
|
1,035.00
-33.53%
|
1,557.00
-14.07%
|
1,812.00
|
| Long Term Debt And Capital Lease Obligation |
|
1,263.00
+77.89%
|
710.00
-41.71%
|
1,218.00
+21.31%
|
1,004.00
|
| Long Term Debt |
|
590.00
|
—
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
673.00
-5.21%
|
710.00
-41.71%
|
1,218.00
+21.31%
|
1,004.00
|
| Tradeand Other Payables Non Current |
|
249.00
+7.79%
|
231.00
-1.70%
|
235.00
|
—
|
| Non Current Deferred Liabilities |
|
153.00
+163.79%
|
58.00
-30.12%
|
83.00
-87.67%
|
673.00
|
| Non Current Deferred Revenue |
|
153.00
+163.79%
|
58.00
-30.12%
|
83.00
-87.67%
|
673.00
|
| Other Non Current Liabilities |
|
36.00
+0.00%
|
36.00
+71.43%
|
21.00
-84.44%
|
135.00
|
| Stockholders Equity |
|
8,650.00
-20.65%
|
10,901.00
-21.32%
|
13,854.00
-27.55%
|
19,123.00
|
| Common Stock Equity |
|
8,650.00
-20.65%
|
10,901.00
-21.32%
|
13,854.00
-27.55%
|
19,123.00
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
394.00
+2.07%
|
386.00
+1.05%
|
382.00
-0.78%
|
385.00
|
| Ordinary Shares Number |
|
394.00
+2.07%
|
386.00
+1.05%
|
382.00
-0.78%
|
385.00
|
| Additional Paid In Capital |
|
1,382.00
+59.58%
|
866.00
+133.42%
|
371.00
-68.37%
|
1,173.00
|
| Retained Earnings |
|
7,223.00
-28.09%
|
10,045.00
-26.17%
|
13,606.00
-25.73%
|
18,320.00
|
| Gains Losses Not Affecting Retained Earnings |
|
45.00
+550.00%
|
-10.00
+91.87%
|
-123.00
+66.76%
|
-370.00
|
| Other Equity Adjustments |
|
45.00
+550.00%
|
-10.00
+91.87%
|
-123.00
+66.76%
|
-370.00
|
| Total Equity Gross Minority Interest |
|
8,650.00
-20.65%
|
10,901.00
-21.32%
|
13,854.00
-27.55%
|
19,123.00
|
| Total Capitalization |
|
9,240.00
-15.24%
|
10,901.00
-21.32%
|
13,854.00
-27.55%
|
19,123.00
|
| Working Capital |
|
4,557.00
-22.67%
|
5,893.00
-19.38%
|
7,310.00
-14.08%
|
8,508.00
|
| Invested Capital |
|
9,240.00
-15.24%
|
10,901.00
-21.32%
|
13,854.00
-27.55%
|
19,123.00
|
| Total Debt |
|
1,305.00
+74.70%
|
747.00
-39.90%
|
1,243.00
+3.58%
|
1,200.00
|
| Capital Lease Obligations |
|
715.00
-4.28%
|
747.00
-39.90%
|
1,243.00
+3.58%
|
1,200.00
|
| Net Tangible Assets |
|
8,553.00
-20.87%
|
10,809.00
-21.43%
|
13,758.00
-28.06%
|
19,123.00
|
| Tangible Book Value |
|
8,553.00
-20.87%
|
10,809.00
-21.43%
|
13,758.00
-28.06%
|
19,123.00
|
| Available For Sale Securities |
|
2,336.00
-6.34%
|
2,494.00
-46.68%
|
4,677.00
-43.77%
|
8,318.00
|
| Current Provisions |
|
509.00
+37.57%
|
370.00
-33.45%
|
556.00
|
—
|
| Investmentin Financial Assets |
|
2,336.00
-6.34%
|
2,494.00
-46.68%
|
4,677.00
-43.77%
|
8,318.00
|
| Notes Receivable |
|
—
|
—
|
0.00
-100.00%
|
36.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-1,873.00
+37.65%
|
-3,004.00
+3.66%
|
-3,118.00
-162.60%
|
4,981.00
|
| Cash Flow From Continuing Operating Activities |
|
-1,873.00
+37.65%
|
-3,004.00
+3.66%
|
-3,118.00
-162.60%
|
4,981.00
|
| Net Income From Continuing Operations |
|
-2,822.00
+20.75%
|
-3,561.00
+24.46%
|
-4,714.00
-156.37%
|
8,362.00
|
| Depreciation Amortization Depletion |
|
215.00
+13.76%
|
189.00
-69.57%
|
621.00
+78.45%
|
348.00
|
| Depreciation And Amortization |
|
215.00
+13.76%
|
189.00
-69.57%
|
621.00
+78.45%
|
348.00
|
| Other Non Cash Items |
|
77.00
+28.33%
|
60.00
+757.14%
|
7.00
-75.00%
|
28.00
|
| Stock Based Compensation |
|
483.00
+12.59%
|
429.00
+40.66%
|
305.00
+34.96%
|
226.00
|
| Deferred Tax |
|
—
|
—
|
828.00
+248.12%
|
-559.00
|
| Deferred Income Tax |
|
—
|
—
|
828.00
+248.12%
|
-559.00
|
| Operating Gains Losses |
|
8.00
-84.62%
|
52.00
+48.57%
|
35.00
|
—
|
| Change In Working Capital |
|
233.00
+398.72%
|
-78.00
-111.32%
|
689.00
+117.16%
|
-4,014.00
|
| Change In Receivables |
|
156.00
-70.79%
|
534.00
+8.32%
|
493.00
-72.46%
|
1,790.00
|
| Changes In Account Receivables |
|
156.00
-70.79%
|
534.00
+8.32%
|
493.00
-72.46%
|
1,790.00
|
| Change In Inventory |
|
-34.00
-140.96%
|
83.00
-88.89%
|
747.00
+51.83%
|
492.00
|
| Change In Prepaid Assets |
|
153.00
+5.52%
|
145.00
-91.95%
|
1,802.00
+179.81%
|
-2,258.00
|
| Change In Payables And Accrued Expense |
|
-94.00
+79.30%
|
-454.00
-38.84%
|
-327.00
-138.38%
|
852.00
|
| Change In Accrued Expense |
|
-2.00
+99.48%
|
-385.00
-13.24%
|
-340.00
-155.56%
|
612.00
|
| Change In Payable |
|
-92.00
-33.33%
|
-69.00
-630.77%
|
13.00
-94.58%
|
240.00
|
| Change In Account Payable |
|
-92.00
-33.33%
|
-69.00
-630.77%
|
13.00
-94.58%
|
240.00
|
| Change In Other Working Capital |
|
41.00
+109.34%
|
-439.00
+78.69%
|
-2,060.00
+50.45%
|
-4,157.00
|
| Change In Other Current Assets |
|
38.00
+171.70%
|
-53.00
+91.24%
|
-605.00
-2980.95%
|
21.00
|
| Change In Other Current Liabilities |
|
-27.00
-125.47%
|
106.00
-83.41%
|
639.00
+184.75%
|
-754.00
|
| Investing Cash Flow |
|
1,946.00
-0.15%
|
1,949.00
-53.66%
|
4,206.00
+181.26%
|
-5,176.00
|
| Cash Flow From Continuing Investing Activities |
|
1,946.00
-0.15%
|
1,949.00
-53.66%
|
4,206.00
+181.26%
|
-5,176.00
|
| Net PPE Purchase And Sale |
|
-192.00
+81.73%
|
-1,051.00
-48.66%
|
-707.00
-76.75%
|
-400.00
|
| Purchase Of PPE |
|
-192.00
+81.73%
|
-1,051.00
-48.66%
|
-707.00
-76.75%
|
-400.00
|
| Capital Expenditure |
|
-202.00
+80.78%
|
-1,051.00
-48.66%
|
-707.00
-76.75%
|
-400.00
|
| Net Investment Purchase And Sale |
|
2,148.00
-28.40%
|
3,000.00
-39.98%
|
4,998.00
+205.53%
|
-4,736.00
|
| Purchase Of Investment |
|
-5,768.00
+11.66%
|
-6,529.00
-72.59%
|
-3,783.00
+66.92%
|
-11,435.00
|
| Sale Of Investment |
|
7,916.00
-16.93%
|
9,529.00
+8.52%
|
8,781.00
+31.08%
|
6,699.00
|
| Net Business Purchase And Sale |
|
0.00
|
0.00
+100.00%
|
-85.00
|
0.00
|
| Purchase Of Business |
|
0.00
|
0.00
+100.00%
|
-85.00
|
0.00
|
| Net Intangibles Purchase And Sale |
|
-10.00
|
0.00
|
0.00
|
—
|
| Purchase Of Intangibles |
|
-10.00
|
0.00
|
0.00
|
—
|
| Net Other Investing Changes |
|
—
|
—
|
-23.00
+42.50%
|
-40.00
|
| Financing Cash Flow |
|
593.00
+958.93%
|
56.00
+104.07%
|
-1,377.00
+60.06%
|
-3,448.00
|
| Cash Flow From Continuing Financing Activities |
|
593.00
+958.93%
|
56.00
+104.07%
|
-1,377.00
+60.06%
|
-3,448.00
|
| Net Issuance Payments Of Debt |
|
560.00
+5700.00%
|
-10.00
+96.30%
|
-270.00
-46.74%
|
-184.00
|
| Issuance Of Debt |
|
600.00
|
0.00
|
0.00
|
—
|
| Repayment Of Debt |
|
-22.00
|
0.00
|
0.00
|
—
|
| Long Term Debt Issuance |
|
600.00
|
0.00
|
0.00
|
—
|
| Long Term Debt Payments |
|
-22.00
|
0.00
|
0.00
|
—
|
| Net Long Term Debt Issuance |
|
560.00
+5700.00%
|
-10.00
+96.30%
|
-270.00
-46.74%
|
-184.00
|
| Net Common Stock Issuance |
|
35.00
-46.97%
|
66.00
+43.48%
|
46.00
+101.41%
|
-3,264.00
|
| Common Stock Payments |
|
—
|
0.00
+100.00%
|
-1,153.00
+65.36%
|
-3,329.00
|
| Repurchase Of Capital Stock |
|
—
|
0.00
+100.00%
|
-1,153.00
+65.36%
|
-3,329.00
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
46.00
-29.23%
|
65.00
|
| Net Other Financing Charges |
|
-2.00
|
—
|
-1,153.00
|
—
|
| Changes In Cash |
|
666.00
+166.67%
|
-999.00
-245.67%
|
-289.00
+92.07%
|
-3,643.00
|
| Effect Of Exchange Rate Changes |
|
2.00
|
0.00
|
0.00
|
—
|
| Beginning Cash Position |
|
1,929.00
-34.12%
|
2,928.00
-8.98%
|
3,217.00
-53.10%
|
6,860.00
|
| End Cash Position |
|
2,597.00
+34.63%
|
1,929.00
-34.12%
|
2,928.00
-8.98%
|
3,217.00
|
| Free Cash Flow |
|
-2,075.00
+48.83%
|
-4,055.00
-6.01%
|
-3,825.00
-183.50%
|
4,581.00
|
| Interest Paid Supplemental Data |
|
10.00
-58.33%
|
24.00
-38.46%
|
39.00
+56.00%
|
25.00
|
| Income Tax Paid Supplemental Data |
|
26.00
-86.80%
|
197.00
|
—
|
2,729.00
|
| Amortization Of Securities |
|
-67.00
+29.47%
|
-95.00
-55.74%
|
-61.00
-296.77%
|
31.00
|
| Change In Income Tax Payable |
|
—
|
—
|
15.00
+101.81%
|
-828.00
|
| Change In Tax Payable |
|
—
|
—
|
15.00
+101.81%
|
-828.00
|
| Common Stock Issuance |
|
35.00
-46.97%
|
66.00
+43.48%
|
46.00
-29.23%
|
65.00
|
| Earnings Losses From Equity Investments |
|
8.00
-84.62%
|
52.00
+48.57%
|
35.00
|
0.00
|
| Issuance Of Capital Stock |
|
35.00
-46.97%
|
66.00
+43.48%
|
46.00
-29.23%
|
65.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-06 View
- 42026-03-06 View
- 8-K2026-03-05 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-03-03 View
- 42026-02-25 View
- 10-K2026-02-20 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 8-K2026-02-13 View
- 8-K2026-02-11 View
- 8-K2026-01-12 View
- 42026-01-06 View
- 8-K2026-01-05 View
- 42025-12-15 View
- 42025-12-15 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|